Feeds:
Posts
Comments

Posts Tagged ‘Date’

Successful termination of “Prohibitive Executory Real Estate Contracts”

Posted in Board Of Intellectual Capital, boic, Distressed IP, Economy, Gerbsman Partners, Intellectual capital, Investments, Life Science, Strategy, Technology, Venture Capital, tagged , , , , , , , , , , , , , , , on June 4, 2009| Leave a Comment »

Steven R. Gerbsman, Principal of Gerbsman Partners, announced today that Gerbsman Partners successfully terminated the executory real estate contracts for two US based life science companies. The venture capital backed companies, executed leases for space in Northern, California. Due to market conditions, both companies made a strategic decision to terminate its corporate space allocation. Faced with potential contingent liabilities in excess of $ 6 million, the companies retained Gerbsman Partners to assist them in the termination of their prohibitive executory real estate contract.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. In the past 72 months, Gerbsman Partners has been involved in maximizing value for 52 Technology, Life Science and Medical Device companies and their Intellectual Property and has restructured/terminated over $780 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception, Gerbsman Partners has been involved in over $2.2 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, Alexandria, VA, San Francisco, Europe and Israel.

For additional information please visit www.gerbsmanpartners.com

Read Full Post »

Yahoo is struggeling on its own – Microsoft merger may inevitable

Posted in Uncategorized, tagged , , , , , , , , , , , , , on April 22, 2009| Leave a Comment »

With a worse than bad report coming out of its first quarter, Yahoo is struggeling to find ways to stand on its own.  In the wake of Oracle/ Sun merge, next large Silicon Valley merge may come very soon. Microsoft who was once considered a no-no in the Valley may look like a saviour!

Here are some coverage tidbits from PCWorld.

“Yahoo had revenue of US$1.58 billion, down 13 percent from the first quarter of 2008 but higher than the $1.20 billion consensus expectation from analysts polled by Thomson Reuters.”

“Meanwhile, net income fell 78 percent to $118 million, or $0.08 per share, compared to $537 million, or $0.37 per share, in the first quarter of 2008, the company said Tuesday. On a pro forma basis, which excludes certain one-time items, Yahoo had net income of $206 million, or $0.15 per share, down 16 percent and 17 percent, respectively, compared to the first quarter of 2008 but exceeding by seven cents per share analysts’ expectation.”

With these bleak numbers, cutbacks will only solve parts of the fundamental problems.

“This time around, Yahoo will let go 5 percent of its staff worldwide. Yahoo ended 2008 with 13,600 employees, so this would mean that about 680 people will be laid off. Yahoo handed out pink slips to about 2,600 employees in two rounds of layoffs last year.”

One may wonder if this is the preparation for a merge with MSFT.

Other coverage on this story can be found at;  Yogi,  MassMedia Now ,  Erik Bowman , 24/7 Wall Street

Read Full Post »

Successful Date Certain M&A of “Business Unit and Intellectual Property”

Posted in Board Of Intellectual Capital, boic, Distressed Intellectual Property, Distressed IP, Gerbsman Partners, Intellectual capital, Venture Capital, tagged , , , , , , , , on April 14, 2009| Leave a Comment »

Steven R. Gerbsman, Principal of Gerbsman Partners, Kenneth Hardesty and Dennis Sholl, members of Gerbsman Partners Board of Intellectual Capital, announced today their success in maximizing stakeholder value for a venture capital backed medical device company that developed a new minimally-invasive treatment option for patients with emphysema.

Gerbsman Partners provided Crisis Management leadership, facilitated the sale of the business unit, associated Intellectual Property and assets and recovered receivables. Due to market conditions, the senior lender and the board of directors made the strategic decision to maximize the value of the business unit and Intellectual Property. Gerbsman Partners provided leadership to the company with:

  • Crisis Management and medical device expertise in developing the strategic action plans for maximizing value of the business unit, Intellectual Property and assets;
  • Proven domain expertise in maximizing the value of the business unit and Intellectual Property through a targeted and proprietary “Date Certain M&A Process”;
  • The ability to “Manage the Process” among potential Acquirers, Lawyers, Creditors Management and Advisors;
  • The proven ability to “Drive” toward successful closure for all parties at interest.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 52 Technology, Life Science and Medical Device companies and their Intellectual Property and has restructured/terminated over $770 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.2 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, San Francisco, Europe and Israel.

Read Full Post »

Emphasys Medical Up For Sale

Posted in Board Of Intellectual Capital, boic, Distressed Intellectual Property, Gerbsman Partners, Intellectual capital, Investments, Life Science, Market research, Strategy, Technology, tagged , , , , , , , , , , , , , , , , , , on February 13, 2009| Leave a Comment »

emphasys-logoEmphasys Medical Inc., a Redwood City, Calif.-based medical device company focused on emphysema, has retained Gerbsman Partners to find a strategic buyer, according to VentureWire. The company canceled an IPO last spring, and before that had raised around $80 million in VC funding. Shareholders include Advanced Technology Ventures (17.8%), Morgenthaler Ventures (13.8%), St. Paul Venture Capital (11.5%) OrbiMed Advisors (13.7%), ABS Ventures (10%), Morgan Stanley Venture Partners (7.4%), Cargill Ventures (6.1%) and Neww Enterprise Associates. www.emphasysmedical.com

Links: peHUB, Biospace, DOW Jones,

Read Full Post »

« Newer Posts